INVO Fertility Inc. Reduces Debenture by $1.3M, Issues 325 Series C-2 Preferred Shares in Exchange Transaction
Invo Fertility Inc., a Nevada corporation, has entered into a share transaction with Five Narrow Lane LP, a Delaware limited partnership. As part of the Amendment and Exchange Agreement effective August 21, 2025, Invo Fertility agreed to issue 325 shares of Series C-2 Preferred Stock to FNL. This transaction was in consideration for reducing the outstanding principal amount of the debenture by $1,300,000, with the shares having an aggregated stated value of $1,300,000.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-025270), on August 22, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.